Literature DB >> 7358869

The role of furosemide alone and in combination with digoxin in the relief of symptoms of congestive heart failure.

D Hutcheon, E Nemeth, D Quinlan.   

Abstract

Clinical and cardiovascular responses to drug therapy with furosemide were compared with those to furosemide plus digoxin in 15 heart patients with sinus rhythm admitted to the hospital for the management of congestive heart failure. Except for two patients in the group treated with furosemide alone, who required the addition of intravenous furosemide for more complete relief of symptoms, the responses to the two therapeutic regimens were not significantly different. One patient in the digoxin-treated group developed atrial fibrillation with frequent ventricular premature beats and transient runs of bigeminal rhythm typical of digitalis toxicity, which disappeared as the dose of digoxin was lowered. Side effects were otherwise considered to be minor and similar in the two groups. The results support the view that the indications for digoxin as a positive inotropic agent in patients with congestive heart failure need to be reevaluated.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7358869     DOI: 10.1002/j.1552-4604.1980.tb01667.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  9 in total

Review 1.  Diuretic therapy in elderly heart failure patients with and without left ventricular systolic dysfunction.

Authors:  D J van Kraaij; R W Jansen; F W Gribnau; W H Hoefnagels
Journal:  Drugs Aging       Date:  2000-04       Impact factor: 3.923

2.  Multicentre comparison between slow-release furosemide and bendroflumethiazide in congestive heart failure.

Authors:  S K Pehrsson
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 3.  Diuretics. Clinical pharmacology and therapeutic use (Part II).

Authors:  A Lant
Journal:  Drugs       Date:  1985-02       Impact factor: 9.546

Review 4.  The treatment of heart failure. A methodological review of the literature.

Authors:  G H Guyatt
Journal:  Drugs       Date:  1986-12       Impact factor: 9.546

5.  [Digitalis therapy: prescription frequency, serum concentrations and withdrawal trials].

Authors:  M Middeke; W Meister; C Krüger; B Krahl; H Holzgreve
Journal:  Klin Wochenschr       Date:  1985-08-16

Review 6.  Digoxin use in congestive heart failure. Current status.

Authors:  K Riaz; A D Forker
Journal:  Drugs       Date:  1998-06       Impact factor: 9.546

Review 7.  Digitalis and heart failure: does digitalis really produce beneficial effects through a positive inotropic action?

Authors:  R Bolognesi; D Tsialtas; C Manca
Journal:  Cardiovasc Drugs Ther       Date:  1992-10       Impact factor: 3.727

Review 8.  Digoxin--a redundant drug in congestive cardiac failure.

Authors:  P A Poole-Wilson; K Robinson
Journal:  Cardiovasc Drugs Ther       Date:  1989-01       Impact factor: 3.727

9.  Digoxin-induced anemia among patients with atrial fibrillation and heart failure: clinical data analysis and drug-gene interaction network.

Authors:  Yubi Lin; Siqi He; Ruiling Feng; Zhe Xu; Wanqun Chen; Zifeng Huang; Yang Liu; Qianhuan Zhang; Bin Zhang; Kejian Wang; Shulin Wu
Journal:  Oncotarget       Date:  2017-06-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.